Pharmaceuticals News

Lexeo Therapeutics Announces Progress in FDA Discussions for Accelerated Approval and Positive Interim Clinical Data for LX2006 in FA Cardiomyopathy

Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile Consistent efficacy demonstrated across age groups MILAN,...

Torino, Italy, October 7 – Resalis Therapeutics, a biotechnology company pioneering microRNA-targeted therapies, presented new preclinical results on its lead candidate RES-010, a first-in-class...

Salipro Biotech secures two new Japanese patents, strengthening its platform for stabilizing challenging membrane proteins to unlock new drug targets.

Dr Saggese will lead the expansion of the company's clinical trials with lead oncolytic immunotherapy THEO-260THEO-260, is currently being investigated in patients with platinum-resistant ovarian...

NEW YORK, 07 oct. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome...

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

Ancien dirigeant de GSK et de Sanofi, M. Monteyne a supervisé le développement de Cervarix® et permis l’avancement de plusieurs traitements pionniers dans les maladies rares ; il apporte dix années...

Former GSK and Sanofi executive, led Cervarix® development and advanced pioneering therapies for rare diseases, decade of experience as venture capitalistStrengthens Bioxodes leadership following...

Spur Therapeutics Presents Updated Phase 1/2 Durability Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress